Propecia suppresses PSA

Article

Dallas - Low-dose Propecia (finasteride, Merck), used to treat hair loss, appears to suppress prostate specific antigen (PSA) levels, which could skew results of prostate cancer tests, researchers say.

Related Videos
Related Content

Overview of Maui Derm NP+PA Fall 2023

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

The Retirement “Red Zone”: What You Need to Know to Score Financially

September 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Journal Digest: September 26

September 26th 2023

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

September 26th 2023

Overview of Maui Derm NP+PA Fall 2023

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

The Retirement “Red Zone”: What You Need to Know to Score Financially

September 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Journal Digest: September 26

September 26th 2023

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

September 26th 2023

Overview of Maui Derm NP+PA Fall 2023

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

The Retirement “Red Zone”: What You Need to Know to Score Financially

September 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Journal Digest: September 26

September 26th 2023

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.